The last paragraph of this article suggests that certain mutations could mean that drugs targeting JAK2 might be useful. Hopefully the day they can genetically test us and determine which drugs would work best for us in coming because one of the hardest things while in a flare up is the trial and error element of trying to get into remission.
"This study in particular also provides evidence that drugs targeting JAK2 may provide some benefit for those patients suffering from IBD who carry mutations that upregulate the JAK2 pathway, though such precision-based approaches would need to be validated in clinical studies."
https://www.sciencedaily.com/releases/2020/04/200409142816.htm